Physician
Internal Medicine
Dr. Vinko M. Bogdanic, MD
|
|
Give Review
Vinko M. Bogdanic, MD works in the field of Internal Medicine. He received 1 awards: "Meaningful Use Stage 1 Certification". Vinko Bogdanic has written publications. He has 51 publications published with PubMed. The lastest publication is: 'Relation between urinary cytology abnormalities and cyclosporine A therapy in bone marrow transplant recipients.' Vinko M. Bogdanic, MD is registered with Medicare and accepts Medicare payments.
Publications
- [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia].
- [Treatment of acute leukemia with allogeneic stem cell transplantation].
- Gemcitabine in the treatment of relapsed and refractory Hodgkin''s disease.
- Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation.
- [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
- [Treatment of chronic myeloid leukemia with imatinib in the accelerated stage of the disease].
- Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.
- Allogeneic stem cell transplantation in treatment of aggressive lymphomas: case series.
- Surgical resection in the treatment of primary gastrointestinal non-Hodgkin''s lymphoma: retrospective study.
- Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study.
- Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin''s disease (Croatian experience).
- Trastuzumab in the treatment of advanced breast cancer: single-center experience.
- Relation between urinary cytology abnormalities and cyclosporine A therapy in bone marrow transplant recipients.
- Treatment of chronic myeloid leukemia in relapse after umbilical cord blood transplantation.
- Anxiety as a possible predictor of acute GVHD.
- Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.
- An autopsy study of systemic fungal infections in patients with hematologic malignancies.
- Prostaglandin E2 for prophylaxis of oral mucositis following BMT.
- Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
- Umbilical cord blood transplantation in a patient with Philadelphia chromosome-positive chronic myeloid leukemia.
- Severe hyperlipidemia following treatment with PUVA for acute skin GVHD.
- High incidence of conservative RAS mutations in acute myeloid leukemia.
- Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
- Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-a...
- Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
- [Bone marrow transplantation].
- [Changes in the skin due to the graft-versus-host reaction. 1. Pathogenesis and diagnosis].
- [Agranulocytosis--incidence and clinical significance (review of 37 of our cases)].
- [Bone marrow cultures from patients with acute myeloid leukemia].
- [Changes in the skin in transplantation versus host reaction. 2. Our clinical findings from observations using light microscopy and electron microscopy].
- Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
- Treatment of acute leukaemia with intensive radiochemotherapy and autologous bone marrow transplantation--Zagreb experience.
- Allogeneic bone marrow transplantation for ALL in Zagreb.
- Allogeneic BMT for AML in Zagreb.
- Aclarubicin in the treatment of de-novo acute myelocytic leukaemia.
- High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia.
- Low-dose Ara-C in the treatment of myelodysplastic syndromes.
- Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
- Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
- [Treatment of neoplastic hematologic diseases with intensive radio-chemotherapy and transplantation of cryopreserved autologous bone marrow].
- Serum neopterin in patients receiving bone marrow transplant.
- Evaluation of renal function in patients treated with bone marrow transplantation.
- The significance of immunological monitoring after allogeneic bone marrow transplantation.
- Elimination of antibodies by plasma exchange in ABO incompatible bone marrow transplantation.
- Donor characteristics in allogeneic bone marrow transplantation.
- Lymphocyte subsets in normal human bone marrow harvested for routine clinical transplantation.
- Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
- Relationship between differing volumes of bone marrow aspirates and their cellular composition.
- High dose ARA-C as induction therapy of acute myeloid leukaemia.
- Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- American Republic
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Iowa PPO
- First Health (Coventry Health Care) PPO
- GEHA
- Health Alliance PPO
- HealthPartners
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- Principal Life
- Thrivent Financial
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Zagreb Faculty of Medicine
Drug Facts
| NPI NUMBER | 1932184249 | |
| NPPES Provider LastName | BOGDANIC | |
| NPPES Provider FirstName | VINKO | |
| NPPES Provider ZIPCode | 507015215 | |
| NPPES Provider State | IA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 12910.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 515.0 | |
| Percent Opioid Claims | 3.99 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932184249 |
| Last Name Of The Provider | BOGDANIC |
| First Name Of The Provider | VINKO |
| View All |
Similar Doctors
|
|
Dr. Hamid R. Amjadi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert S. Grittmann, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amit Monga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brent E. Buhr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hamid R. Amjaid, DO |
|
|
Dr. Hriden N. Basu, MD |
|
|
Dr. Ahsan Maqsood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Redfern, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen R. Yalamanchili, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Swapnesh V. Parikh, MD |
|
|
Dr. Toufic A. Kachaamy, MD |